Collaboration for pharmaceutical engineering and science
You are here:
members › Rex Reklaitis › Contributions
Pharmacokinetic based design of individualized dosage regimens
0.0 out of 5 stars
10 May 2011 | Teaching Materials | Contributor(s): Jose Miguel Lainez, Gary Blau, Linas Mockus, Seza Orcun, Rex Reklaitis
Clinical trials and health care studies generate an enormous amount of data. This data is used by pharmaceutical companies during new drug development processes to characterize patient populations and determine a standardized dosage regimen for new patients. Nevertheless, the knowledge embedded...